These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 33756415)

  • 21. Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia - A controlled cross-sectional study.
    Ranzolin A; Duarte AL; Bredemeier M; da Costa Neto CA; Ascoli BM; Wollenhaupt-Aguiar B; Kapczinski F; Xavier RM
    Cytokine; 2016 Aug; 84():25-8. PubMed ID: 27209553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between brain-derived neurotrophic factor levels, oxidative and nitrosative stress and depressive symptoms: a study on peritoneal dialysis.
    Eraldemir FC; Ozsoy D; Bek S; Kir H; Dervisoglu E
    Ren Fail; 2015 May; 37(4):722-6. PubMed ID: 25687386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of motor rehabilitation training on clinical symptoms and serum BDNF levels in Parkinson's disease subjects.
    Angelucci F; Piermaria J; Gelfo F; Shofany J; Tramontano M; Fiore M; Caltagirone C; Peppe A
    Can J Physiol Pharmacol; 2016 Apr; 94(4):455-61. PubMed ID: 26863448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory cytokines and NT-proCNP in Parkinson's disease patients.
    Koziorowski D; Tomasiuk R; Szlufik S; Friedman A
    Cytokine; 2012 Dec; 60(3):762-6. PubMed ID: 22910321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of cortisol and neurotrophic factor brain-derived in Parkinson's disease.
    Costa CM; Oliveira GL; Fonseca ACS; Lana RC; Polese JC; Pernambuco AP
    Neurosci Lett; 2019 Aug; 708():134359. PubMed ID: 31265872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Panel of Oxidative Stress and Inflammatory Biomarkers in ALS: A Pilot Study.
    Blasco H; Garcon G; Patin F; Veyrat-Durebex C; Boyer J; Devos D; Vourc'h P; Andres CR; Corcia P
    Can J Neurol Sci; 2017 Jan; 44(1):90-95. PubMed ID: 27774920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative Stress, Pro-Inflammatory Cytokines, and Antioxidants Regulate Expression Levels of MicroRNAs in Parkinson's Disease.
    Prasad KN
    Curr Aging Sci; 2017; 10(3):177-184. PubMed ID: 28042771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do adipose tissue-derived mesenchymal stem cells ameliorate Parkinson's disease in rat model?
    Ahmed H; Salem A; Atta H; Ghazy M; Aglan H
    Hum Exp Toxicol; 2014 Dec; 33(12):1217-31. PubMed ID: 24567299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive Rehabilitation Enhances Lymphocyte BDNF-TrkB Signaling in Patients With Parkinson's Disease.
    Fontanesi C; Kvint S; Frazzitta G; Bera R; Ferrazzoli D; Di Rocco A; Rebholz H; Friedman E; Pezzoli G; Quartarone A; Wang HY; Ghilardi MF
    Neurorehabil Neural Repair; 2016 Jun; 30(5):411-8. PubMed ID: 26253177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of oxidative stress and brain-derived neurotrophic factor levels related to crack-use detoxification.
    Hirsch GE; Jaskulski M; Hamerski HM; Porto FG; da Silva B; Aita CAM; Kroker K; de Bem Silveira G; Silveira PCL; Santos GT; Klafke JZ; Viecili PRN
    Neurosci Lett; 2018 Mar; 670():62-68. PubMed ID: 29374540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colonic inflammation in Parkinson's disease.
    Devos D; Lebouvier T; Lardeux B; Biraud M; Rouaud T; Pouclet H; Coron E; Bruley des Varannes S; Naveilhan P; Nguyen JM; Neunlist M; Derkinderen P
    Neurobiol Dis; 2013 Feb; 50():42-8. PubMed ID: 23017648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.
    Dzamko N; Rowe DB; Halliday GM
    Mov Disord; 2016 Jun; 31(6):889-97. PubMed ID: 26917005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease.
    Fischer DL; Auinger P; Goudreau JL; Paumier KL; Cole-Strauss A; Kemp CJ; Lipton JW; Sortwell CE
    Parkinsonism Relat Disord; 2018 Aug; 53():70-75. PubMed ID: 29759928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.
    Dursun E; Gezen-Ak D; Hanağası H; Bilgiç B; Lohmann E; Ertan S; Atasoy İL; Alaylıoğlu M; Araz ÖS; Önal B; Gündüz A; Apaydın H; Kızıltan G; Ulutin T; Gürvit H; Yılmazer S
    J Neuroimmunol; 2015 Jun; 283():50-7. PubMed ID: 26004156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of neurotrophic factors are unchanged in patients with Parkinson's disease.
    Rocha NP; Ferreira JPS; Scalzo PL; Barbosa IG; Souza MS; Christo PP; Reis HJ; Teixeira AL
    Arq Neuropsiquiatr; 2018 May; 76(5):310-315. PubMed ID: 29898077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
    Stringham NT; Holmes PV; Stringham JM
    Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The possible role of an autoimmune mechanism in the etiopathogenesis of Parkinson's disease.
    Dalitis S; Filippidou N; Krashias G; Christodoulou C; Pantzaris M; Lambrianides A
    J Clin Neurosci; 2018 Aug; 54():63-68. PubMed ID: 29907389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotrophic and inflammatory markers in bipolar disorder: A prospective study.
    van den Ameele S; Coppens V; Schuermans J; De Boer P; Timmers M; Fransen E; Sabbe B; Morrens M
    Psychoneuroendocrinology; 2017 Oct; 84():143-150. PubMed ID: 28711724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.